Prostate cancer claims in Hong Kong nearly doubled in two years. In Singapore, breast cancer is diagnosed on average at age 48. In Thailand, cancer risks are spread across a wide range of categories, with no single dominant type. For HR leaders and business decision-makers managing workforces across Asia, these are not isolated data points. They reflect a shifting reality that is reshaping how organisations should think about employee health, benefits design, and workforce resilience.
APRIL International recently analysed cancer claims data across Singapore, Hong Kong, and Thailand between 2023 and 2025. The findings point to three clear trends, each with direct implications for how companies design and deliver employee health benefits.
Cancer prevention is no longer a wellness perk. It is a workforce strategy issue.
Trend 1: Cancer is affecting employees earlier than many expect
A common assumption is that cancer primarily affects older populations. Our data tells a different story. In 2025, the average age of diagnosis across our claims was:
48 for breast cancer
43 for cervical cancer
43 for skin cancer
41 for thyroid cancer
These are employees at the peak of their working lives. They manage teams, drive growth, mentor colleagues, and often raise families. When cancer strikes at this stage, the impact extends well beyond the individual, affecting team continuity, leadership succession, and organisational performance.
Breast cancer is especially significant, remaining one of the most common cancer types across the markets analysed and consistently diagnosed during prime working years. For HR leaders, the takeaway is clear: cancer support cannot be reserved for older employees. It needs to be embedded in the mainstream benefits strategy for the entire workforce.
Trend 2: Cancer risks differ significantly by market
Cancer profiles vary considerably across Asia. For regional employers, this is a critical consideration.
Singapore: female cancers dominate the claims profile. Breast cancer is the leading category, with cervical, ovarian, and uterine cancers also contributing significantly. This points to the importance of female health education, preventive screening, and benefits that support early detection of gynaecological cancers.
Hong Kong: prostate cancer is rising sharply. Prostate cancer claims rose from 10.6 percent in 2023 to 20 percent in 2025. This near doubling highlights the growing need for men's health awareness, particularly as workforces age.
Thailand: cancer claims are more evenly distributed. Rather than one dominant cancer type, Thailand shows a broader spread across categories. Employers here may benefit less from targeted campaigns and more from comprehensive prevention strategies covering a wide range of risks.
The implication is clear. A one-size-fits-all wellness strategy is unlikely to work across Asia. Benefits, communications, and prevention campaigns need to reflect the realities of each local workforce, and increasingly, benefits design should be informed by real claims data rather than assumptions.
Trend 3: Early detection is a business lever, not just a health message
Early detection remains one of the most effective ways to improve outcomes. For cancers such as breast, cervical, prostate, and colorectal, screening can identify risks before symptoms become serious, often making the difference between a treatable condition and a life-changing diagnosis.
The business implications are equally significant. Late-stage treatment typically involves longer absences, more complex care pathways, higher medical costs, and greater strain on teams. Employers who invest in early detection tend to see better recovery outcomes, faster return to work, and more predictable healthcare costs.
However, screening only works when employees use it. In many Asian markets, stigma around certain cancers, reluctance to take time off for preventive care, and gaps in health literacy can suppress uptake, even when strong benefits are in place. Employers can play a powerful role by promoting preventive care actively, making benefits easier to understand, and normalising health checks within workplace culture.
What this means for HR and business leaders
Cancer support does not begin at diagnosis. A strong benefits strategy should support the full employee journey, from prevention and screening through to treatment, recovery, and emotional well-being. Based on what we see in our claims data across Asia, we recommend four priorities:
Design benefits around actual workforce risks. Use claims data, demographics, and local market insights to shape coverage rather than defaulting to generic plans.
Invest in comprehensive cancer coverage. Include diagnostics, specialist care, treatment, medication, and follow-up. Direct billing and access to expert medical networks can significantly reduce stress during treatment.
Make prevention visible and easy. Screening benefits are only as useful as their uptake. Education, targeted campaigns, reminders, and manager training translate benefits into behaviour.
Support employees holistically. Flexible work arrangements, mental health support, second medical opinion services, and expert guidance during complex treatment decisions all contribute to better outcomes and stronger loyalty.
The bigger picture
The question for HR and business leaders is no longer whether cancer will affect their workforce. The data makes clear that it already does, often earlier than expected and in ways that vary significantly by market. The real question is whether the benefits strategy in place today is ready to respond when it matters.
At APRIL International, we work with organisations in Asia and beyond to build health benefits that help employees access the right care at the right time. Our claims data does more than shape our products. It helps our clients make informed, evidence-based decisions about how they protect and support their people.
To learn how APRIL International can help strengthen your employee health benefits strategy, speak with your broker or contact our team at corporate.asia@april.com or +65 6320 9583.
